| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.67B | +2.5% |
| Cost of Revenue | $1.21B | +1.0% |
| Gross Profit | $462.1M | +6.8% |
| R&D Expense | $40.6M | -4.5% |
| SG&A Expense | $187.6M | +7.4% |
| Operating Income | $266.2M | +7.2% |
| Pre-tax Income | $234.8M | +3.7% |
| Income Tax | $49.2M | -10.7% |
| Net Income | $185.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $184.3M | +9.7% |
| Accounts Receivable | $254.2M | +37.8% |
| Inventory | $266.6M | +6.6% |
| Current Assets | $755.0M | +8.9% |
| Total Assets | $1.19B | +9.3% |
| Current Liabilities | $344.9M | -8.0% |
| Long-term Debt | $592.5M | -1.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $105.4M | -44.2% |
| Capital Expenditures | $48.6M | +6.1% |
| Investing Cash Flow | -$48.6M | -6.1% |
| Financing Cash Flow | -$35.8M | -244.4% |
| Free Cash Flow | $56.8M | -60.3% |
| +8.3% |
| EPS (Basic) | $2.23 | +8.3% |
| EPS (Diluted) | $2.22 | +8.3% |
| Total Liabilities |
| $962.9M |
| -4.5% |
| Stockholders' Equity | $227.4M | +181.8% |